SC 13G Filing

Company

ADMA BIOLOGICS, INC.

Filed

February 11, 2022

Accession Number

0000930413-22-000208

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →